Status:
RECRUITING
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia
Lead Sponsor:
Centre hospitalier de Ville-Evrard, France
Conditions:
Schizophrenia
Hallucinations
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The regions which are assumed to underlie the pathophysiology of schizophrenia, namely hypoactivity at the prefrontal level and pathological hyperactivity of the associative regions of the language lo...
Detailed Description
Hearing hallucinations are one of the major symptoms of schizophrenia. In 30% of patients they are resistant to common psychotropic treatments. tDCS (Transcranial Direct Current Stimulation) is a tech...
Eligibility Criteria
Inclusion
- Schizophrenia according to DSM-V.
- Refractory auditory hallucinations(despite two antipsychotics trials).
- Right-handed patients.
- Written informed consent.
Exclusion
- Presence of other psychiatric disorders than schizophrenia (except addiction to tobacco or caffeine ).
- History of severe head trauma or coma.
- History of epilepsy or neurological disorder or a general medical condition.
- Presence of intracranial metallic objects or pacemaker.
- Hospitalized patients without consent.
- pregnant women .
Key Trial Info
Start Date :
May 3 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04352569
Start Date
May 3 2016
End Date
March 10 2026
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
unité de recherche clinique de l'E.P.S de Ville Evrard
Neuilly-sur-Marne, France, 93332